Efficacy and Safety of Once-Weekly Subcutaneous Semaglutide in Overweight or Obese Adults: A Systematic Review with Meta-Analysis.

Background: To evaluate the efficacy and safety of once-weekly subcutaneous semaglutide treatment in overweight or obese patients without type 2 diabetes.

Methods: Randomized clinical trials that assessed the impact of once-weekly semaglutide on body weight and safety outcomes in overweight or obese patients were retrieved from PubMed, EMBASE, and Lilacs up to November 2023. Risk of bias was assessed with RoB 2.

Authentic leadership in nurses' professional practice: an integrative review.

Objectives: to identify the primary constructs concerning authentic leadership and its relevance for nurses' professional practice.

Methods: integrative literature review conducted between 2015 and 2020 in LILACS, SciELO, and PubMed databases.

Results: the United States published most of the 31 studies analyzed, with eight studies (25.